Although it has previously been argued that a lack of efficacy of IVIG in AD patients may be due to the inclusion of patients with an advanced disease stage [12], our results do not support this hypothesis, as there was no association between serum Igs and dementia risk in our population free from dementia at study baseline. The gene discussed is CUBN; the disease is dementia.